Otros idiomas PYC Therapeutics Limited

Acciones

PYC

AU000000PYC7

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:44 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,092 ^AUD	-1,08 %		+1,10 %	-16,36 %

22/04	Las acciones australianas repuntan ante el alivio de las tensiones en Oriente Medio y a la espera de los datos de inflación local	MT
10/04	PYC Therapeutics recauda 13,5 millones de dólares australianos a través de una oferta minorista; se anuncia una colocación minorista de derechos por valor de 21,2 millones de dólares australianos	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Australian Shares Rebound Amid Easing Middle East Tensions, Ahead of Local Inflation Data	22/04
PYC Therapeutics Confirms Safety, Tolerability of Kidney Medication in Animal Study	22/04
PYC Therapeutics Raises AU$13.5 Million via Retail Offer; AU$21.2 Million Retail Shortfall Placement Announced	10/04
PYC Therapeutics Raises AU$40 Million via Entitlement Offer	18/03
PYC Therapeutics to Raise Up to AU$75 Million for Advancing Drug Candidates	14/03
PYC Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02
PYC Therapeutics Receives AU$4.5 Million Upfront Fee for Drug Discovery Collaboration	16/02
PYC Therapeutics to Launch Google Cloud-Hosted Drug Discovery Project; Shares Fall 5%	02/01
Pyc Therapeutics Announces the Results of A Study Conducted in Human 3-Dimensional Models Derived from Patients with End-Stage Renal Failure Due to Autosomal Dominant Polycystic Kidney Disease	13/11
PYC Therapeutics Completes Dosing in Second Patient Cohort for Retinitis Pigmentosa Clinical Trial	03/11
PYC Reports Positive Results from Preclinical Studies of Rare Eye Disease Drug	05/10/23
PYC Therapeutics Advances to Second Dose Cohort of Phase 1 Trial Following Safety Clearance	22/09/23
PYC Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
PYC Therapeutics Limited Announces US FDA Designates PYC's Lead as a Fast Track Development Program	11/08/23
PYC Therapeutics Raises Vision Pharma Shareholding to 96.2%	10/08/23
PYC Therapeutics' RP11 Investigational Drug Candidate Secures Fast Track Designation from US FDA; Shares Climb 3%	02/08/23
PYC Therapeutics Completes Toxicology Testing of Retinitis Pigmentosa Medication	18/07/23
PYC Therapeutics Doses First Patient in Blinding Eye Disease Trial	30/06/23
Pyc Appoints Andrew Taylor as Joint Company Secretary	01/06/23
PYC Therapeutics to Raise AU$30 Million in Placement	11/05/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas PYC Therapeutics Limited

Acciones

PYC

AU000000PYC7

Otros idiomas

Filtros